脑机接口概念刺激翔宇医疗股价大涨，重要股东抛出减持计划引投资者质疑

Core Viewpoint - The major shareholder of Xiangyu Medical has announced a plan to reduce its stake, which raises questions among investors about the company's optimistic outlook on its brain-computer interface products and business prospects [1] Group 1: Shareholder Actions - The controlling shareholder's action, An'yang Qixu Trade Consulting Service Center, plans to reduce its holdings by up to 3% of the total share capital between February 4, 2026, and May 3, 2026 [1] - This reduction comes after a significant increase in the company's stock price, driven by enthusiasm in the brain-computer interface sector [1] Group 2: Market Reactions - Investors have expressed skepticism on social media regarding the decision to reduce holdings, questioning the rationale behind the sell-off given the company's previous optimistic statements about its brain-computer interface products [1] - The company appeared optimistic during discussions with various institutions regarding its brain-computer interface-related products and business outlook [1]